Detalles de la búsqueda
1.
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Prostate
; 84(10): 954-958, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38641986
2.
Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort.
Prostate
; 83(6): 547-554, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632656
3.
Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer.
Prostate
; 83(12): 1186-1192, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211963
4.
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
Oncologist
; 28(6): 465-473, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37027449
5.
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL.
Mol Imaging
; 2022: 7056983, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35283693
6.
Bipolar androgen therapy (BAT): A patient's guide.
Prostate
; 82(7): 753-762, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35357024
7.
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.
Prostate
; 80(5): 407-411, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31972048
8.
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on 18F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer.
J Urol
; 204(3): 496-502, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32250727
9.
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Prostate
; 78(5): 401-407, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29368341
10.
Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate.
Prostate
; 78(13): 992-1000, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29851094
11.
Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide.
Prostate
; 76(16): 1484-1490, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27404039
12.
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Nat Commun
; 15(1): 14, 2024 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38167882
13.
Role of bromodomain and extraterminal (BET) proteins in prostate cancer.
Expert Opin Investig Drugs
; 32(3): 213-228, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857796
14.
Vascular Expression of Prostate-specific Membrane Antigen (PSMA) in MiTF Family Translocation Renal Cell Carcinoma and Related Neoplasms.
Appl Immunohistochem Mol Morphol
; 31(8): 544-549, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37471632
15.
Multi-timepoint imaging with PSMA-targeted [18F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging.
Ann Nucl Med
; 37(4): 246-254, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857019
16.
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
bioRxiv
; 2023 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865273
17.
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis.
J Neurosurg Spine
; 39(2): 278-286, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148233
18.
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
JCI Insight
; 8(24)2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971875
19.
Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss.
Eur Urol Open Sci
; 41: 112-115, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35677016
20.
Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy.
Clin Genitourin Cancer
; 20(2): 97-101, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34538582